regulatory reports
Message from the Regulators: Pharmacovigilance to Move Heavily into Risk-Benefit Assessment
November 25 by Pharma IQPilar Carrero Director of Safety Medical Writing at Novo Nordisk, joins Andrea Charles from Pharma IQ, to discuss the impact social media has had on drug safety and risk managment and the dawn...